Talazoparib (Tala) For Patients With Germline Brca1/2 Mutated (Gbrca1/2mut) Advanced Breast Cancer (Abc): Characteristics Of Patients Who Experienced Hematologic Toxicity In The Phase Iii Embraca Trial

S. A. Hurvitz, H. S. Rugo, J. Ettl,M. Martin,H. Roche,K-H. Lee, A. Goodwin, T. Usari, S. Lanzalone, C. A. Guenzel,J. Blum, J. K. Litton

ANNALS OF ONCOLOGY（2021）

引用 0|浏览6